1. Home
  2. AVTX vs SCWO Comparison

AVTX vs SCWO Comparison

Compare AVTX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • SCWO
  • Stock Information
  • Founded
  • AVTX 2011
  • SCWO 2021
  • Country
  • AVTX United States
  • SCWO United States
  • Employees
  • AVTX N/A
  • SCWO N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • AVTX Health Care
  • SCWO Utilities
  • Exchange
  • AVTX Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • AVTX 88.4M
  • SCWO 64.3M
  • IPO Year
  • AVTX 2015
  • SCWO N/A
  • Fundamental
  • Price
  • AVTX $7.35
  • SCWO $0.36
  • Analyst Decision
  • AVTX Strong Buy
  • SCWO
  • Analyst Count
  • AVTX 4
  • SCWO 0
  • Target Price
  • AVTX $33.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • AVTX 54.4K
  • SCWO 338.1K
  • Earning Date
  • AVTX 03-28-2025
  • SCWO 03-28-2025
  • Dividend Yield
  • AVTX N/A
  • SCWO N/A
  • EPS Growth
  • AVTX N/A
  • SCWO N/A
  • EPS
  • AVTX N/A
  • SCWO N/A
  • Revenue
  • AVTX $820,000.00
  • SCWO $313,930.00
  • Revenue This Year
  • AVTX N/A
  • SCWO N/A
  • Revenue Next Year
  • AVTX N/A
  • SCWO $5,180.00
  • P/E Ratio
  • AVTX N/A
  • SCWO N/A
  • Revenue Growth
  • AVTX N/A
  • SCWO N/A
  • 52 Week Low
  • AVTX $4.18
  • SCWO $0.30
  • 52 Week High
  • AVTX $34.46
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 42.79
  • SCWO 26.59
  • Support Level
  • AVTX $7.42
  • SCWO $0.30
  • Resistance Level
  • AVTX $8.50
  • SCWO $0.58
  • Average True Range (ATR)
  • AVTX 0.64
  • SCWO 0.06
  • MACD
  • AVTX 0.02
  • SCWO 0.00
  • Stochastic Oscillator
  • AVTX 17.16
  • SCWO 21.96

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: